Explore how lived patient experiences are transforming clinical trials and corporate leadership in the life sciences sector.
A new risk assessment model developed by investigators from the Blood & Marrow Transplant Clinical Trials Network (BMT CTN) will be presented by Fred Hutch Cancer Center transplant doctor Mohamed ...
An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results